COVID-19 Trial - Supplementary material/Thoughts, page-4

this is why I like hotcopper, people such as yourself with more knowledge in areas than I may have can correct any information I have.

Admittedly I didn’t pay much attention to the drug development phase of my course (Much rather the clinical side of things in practice),

would you be able to clear up for me why the company would call this a phase II when you are saying that this somehow isn’t a phase II study?



whilst I do appreciate you commenting, I would appreciate it if you could read the entirety of the post instead of one section and claiming I am entirely wrong from the get go, and perhaps even explaining your reasoning apart from just stating things.